Filing Details
- Accession Number:
- 0001179110-18-000677
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-08 15:36:50
- Reporting Period:
- 2017-01-08
- Accepted Time:
- 2018-01-08 15:36:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
855654 | Immunogen Inc | IMGN | Pharmaceutical Preparations (2834) | 042726691 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1629767 | J. Richard Gregory | C/O Immunogen, Inc. 830 Winter Street Waltham MA 02451 | Executive Vp & Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-01-08 | 2,904 | $6.64 | 273,577 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Weighted average price of shares sold.
- The transaction reported in this Form 4 was made in connection with the satisfaction of the reporting person's tax withholding obligation arising from the vesting of restricted shares and was effected pursuant to a 10b5-1 trading plan executed by the reporting person on December 11, 2015.